-
May 10, 2012
New Screening Technique from Scripps Research Institute Yields Elusive Compounds to Block Immune-Regulating Enzyme
Scientists at The Scripps Research Institute have found the first chemical compounds that act to block an enzyme that has been linked to inflammatory conditions such as asthma and arthritis, as well as some inflammation-promoted cancers.
-
May 07, 2012
Scripps Research Institute Scientists Show How Memory B Cells Stay 'In Class' to Fight Different Infections
Scientists at The Scripps Research Institute have made an important discovery about the internal programming of B cells, the immune cells that make antibodies against infections.
-
May 03, 2012
Scripps Research Institute and UC San Diego Study Reveals Dynamic Changes in Gene Regulation in Human Stem Cells
A team led by scientists at The Scripps Research Institute and the University of California (UC) San Diego has discovered a new type of dynamic change in human stem cells.
-
May 03, 2012
Scripps Research Institute Scientists Show How a Gene Duplication Helped our Brains Become 'Human'
What genetic changes account for the vast behavioral differences between humans and other primates? Researchers so far have catalogued only a few, but now it seems that they can add a big one to the list.
-
April 26, 2012
Scripps Research Institute Scientists Find the Structure of a Key ‘Gene Silencer’ Protein
Scientists at The Scripps Research Institute have determined the three-dimensional atomic structure of a human protein that is centrally involved in regulating the activities of cells.
-
April 26, 2012
Scripps Research Institute Scientists Solve a Mystery of Bacterial Growth and Resistance
Scientists at The Scripps Research Institute have unraveled a complex chemical pathway that enables bacteria to form clusters called biofilms. Such improved understanding might eventually aid the development of new treatments targeting biofilms, which are involved in a wide variety of human infections and help bacteria resist antibiotics.
-
April 23, 2012
Scripps Research Scientists Find Anticonvulsant Drug Helps Marijuana Smokers Kick The Habit
Scientists at The Scripps Research Institute have found clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, helps people to quit smoking marijuana (cannabis).
-
April 22, 2012
Scripps Research Wins $10.2 Million Grant to Develop New Therapies for Eye Diseases
A team led by a scientist from The Scripps Research Institute has been awarded a five-year, $10.2 million grant from the National Eye Institute (NEI) to develop a new type of treatment for diabetic retinopathy, macular degeneration, and other common vision disorders.
-
April 19, 2012
Scientist Wins $3 Million Renewal of One of Longest-Running NIH Grants to Scripps Research
The Scripps Research Institute has received a $3 million grant renewal from the National Institutes of Health (NIH) for support of scientist James Hoch’s studies on bacterial signaling proteins.
-
April 18, 2012
Scripps Research Institute Scientists Develop Antidote for Cocaine Overdose
Scientists at The Scripps Research Institute have shown that an injectable solution can protect mice from an otherwise lethal overdose of cocaine.
-
April 17, 2012
Scripps Research Institute Professor Gerald F. Joyce Elected to American Academy of Arts & Sciences
Scripps Research Institute Professor Gerald F. Joyce, MD, PhD, has been elected to the American Academy of Arts & Sciences.
-
April 03, 2012
New Life Sciences Networking Group Announces Panel Discussion on Intellectual Property
As one of its first events, a new life sciences networking group in town, Oxbridge Biotech Roundtable (OBR)-San Diego, will host a panel discussion on intellectual property’s role in creating successful businesses, scheduled for Wednesday, April 11, 6 to 9 PM.
-
April 02, 2012
Scripps Research Institute Scientists Find Promising Vaccine Targets on Hepatitis C Virus
A team led by scientists at The Scripps Research Institute has found antibodies that can prevent infection from widely differing strains of hepatitis C virus (HCV) in cell culture and animal models.
-
March 23, 2012
The Scripps Research Institute Hosts NOBCChE Western Regional Meeting
The Scripps Research Institute is hosting the Western regional meeting of the National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE) this weekend.
-
March 22, 2012
Scripps Research Institute Team Wrests Partial Control of a Memory
Scripps Research Institute scientists and their colleagues have successfully harnessed neurons in mouse brains, allowing them to at least partially control a specific memory.
-
March 22, 2012
Scripps Research Institute High School Program Receives CIRM Grant
The Scripps Research Institute is one of the institutions that will receive funding from the California Institute for Regenerative Medicine (CIRM)—the state stem cell agency created by proposition 71—to foster creativity and scientific innovation in high school students and fund basic stem cell discoveries, CIRM announced today.
-
March 21, 2012
Interview and Photo Opportunity:
The Scripps Research Institute Hosts NOBCChE Regional Meeting
The Scripps Research Institute will host the National Organization for the Professional Advancement of Black Chemists and Chemical Engineers (NOBCChE) West Regional meeting, March 23-25, featuring scientific presentations, a tour of Scripps Research laboratories, student poster session, science teacher workshop, and participant networking.
-
March 21, 2012
Team led by Scripps Research Institute Scientists Finds Atomic Structure of Molecule that Binds to Opioids in the Brain
Scientists have for the first time determined the three-dimensional atomic structure of a human opioid receptor, a molecule on the surface of brain cells that binds to opioids and is centrally involved in pleasure, pain, addiction, depression, psychosis, and related conditions.
-
March 06, 2012
Scripps Research Discoveries Lead to Newly Approved Drug for Infant Respiratory Distress Syndrome
Scientific advances at The Scripps Research Institute have led to a new drug Surfaxin® (lucinactant), approved today by the U.S. Food and Drug Administration (FDA) to treat infant respiratory distress syndrome.
-
February 21, 2012
Scripps Research Scientists Unlock Evolutionary Secret of Blood Vessels
The ability to form closed systems of blood vessels is one of the hallmarks of vertebrate development.
-
February 19, 2012
Scripps Research Scientists Identify Protein that Sends ‘Painful Touch’ Signals
In two landmark papers in the journal Nature this week, scientists at The Scripps Research Institute report that they have identified a class of proteins that detect “painful touch.”
-
February 16, 2012
Scripps Research and Sanford-Burnham scientists shed light on how body fends off bacteria
To invade organisms such as humans, bacteria make use of a protein called flagellin, part of a tail-like appendage that helps the bacteria move about.
-
February 16, 2012
Scripps Research Scientists Create New Molecular Map to Guide Development of New Treatments for Multiple Sclerosis and Other Diseases
A team of scientists from The Scripps Research Institute, collaborating with members of the drug discovery company Receptos, has created the first high-resolution virtual image of cellular structures called S1P1 receptors, which are critical in controlling the onset and progression of multiple sclerosis and other diseases.
-
February 09, 2012
Ultraviolet Protection Molecule in Plants Yields Its Secrets to Scripps Research Team
Lying around in the sun all day is hazardous not just for humans but also for plants, which have no means of escape.
-
February 07, 2012
Scripps Research and Technion Scientists Develop Biological Computer to Encrypt and Decipher Images
Scientists at The Scripps Research Institute in California and the Technion–Israel Institute of Technology have developed a “biological computer” made entirely from biomolecules that is capable of deciphering images encrypted on DNA chips.
-
February 02, 2012
Team Led by Scripps Research Scientists Demonstrates Effective New ‘Biopsy in a Blood Test’ to Detect Cancer
Scientists from The Scripps Research Institute, Scripps Health, and collaborating cancer physicians have successfully demonstrated the effectiveness of an advanced blood test for detecting and analyzing circulating tumor cells (CTCs)—breakaway cells from patients’ solid tumors—from cancer patients.
-
February 02, 2012
Scripps Research Alumnus Wins International Science & Engineering Visualization Challenge
A powerful 3D animation tool created by Graham Johnson at The Scripps Research Institute has been selected as the winning video in the ninth annual International Science & Engineering Visualization Challenge.
-
January 31, 2012
Scripps Research Team Proves Plausibility of New Primordial Pathway to Life’s Chemical Building Blocks
A group from The Scripps Research Institute has proven an alternative pathway to life-essential sugars called the glyoxylate scenario, which may push the field of pre-life chemistry past the formose reaction hurdle.
-
January 26, 2012
Scripps Research Scientists Illuminate Cancer Cells’ Survival Strategy During Dangerous Dissemination
A team led by scientists at The Scripps Research Institute has discovered key elements of a strategy commonly used by tumor cells to survive when they spread to distant organs.
-
January 25, 2012
Scripps Research Institute Names Peter K. Vogt as Senior Vice President for Scientific Affairs
The Scripps Research Institute has named Professor Peter K. Vogt, PhD, as senior vice president for scientific affairs.
-
January 22, 2012
Scripps Research Scientists Provide New Understanding of Chronic Pain
Millions of people worldwide suffer from a type of chronic pain called neuropathic pain, which is triggered by nerve damage.
-
January 02, 2012
Michael A. Marletta Takes Office as New President of Scripps Research Institute
Renowned biochemist Michael A. Marletta, PhD, assumed the post of president and CEO of The Scripps Research Institute January 1, succeeding Richard A. Lerner, MD, who led the institution for more than two decades.